SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-22-043040
Filing Date
2022-11-23
Accepted
2022-11-23 17:15:53
Documents
13
Period of Report
2022-11-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K brhc10044578_8k.htm   iXBRL 8-K 29806
  Complete submission text file 0001140361-22-043040.txt   210960

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA roiv-20221117.xsd EX-101.SCH 4370
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE roiv-20221117_def.xml EX-101.DEF 18159
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE roiv-20221117_lab.xml EX-101.LAB 28150
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE roiv-20221117_pre.xml EX-101.PRE 20401
7 EXTRACTED XBRL INSTANCE DOCUMENT brhc10044578_8k_htm.xml XML 6557
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE, 2 CHURCH STREET HAMILTON HM11 D0 HM11 441-295-5950
Roivant Sciences Ltd. (Filer) CIK: 0001635088 (see all company filings)

IRS No.: 981173944 | State of Incorp.: D0 | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-40782 | Film No.: 221417080
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences